Therapeutic Dietary Supplement Manufacturing & Formulation

The contract seeks the manufacture of an unflavored, lactose-free therapeutic dietary supplement in powder form, with each packet containing 80 grams of product designed to be reconstituted into 8 to 10 ounces of liquid. The formulation must strictly comply with both FDA regulations and U.S. military nutritional standards, ensuring suitability for therapeutic use in controlled environments. Production must maintain consistent quality, stability, and safety profiles to meet the rigorous requirements of institutional and clinical applications under military oversight. The opportunity is issued as a subcontract under the NAICS code 325411 for Pharmaceutical and Biological Product Manufacturing, with a response deadline of August 5, 2026. Performance is required at Perry Point, Maryland, 21902, under the purview of the Department of Defense’s Medical Supply Chain PHFS. The solicitation is open to qualified manufacturers capable of scaling production reliably while adhering to all regulatory and nutritional specifications, with no set-aside provisions indicated. Bidders must ensure full alignment with the technical and compliance conditions outlined in the contract’s governing framework.